Arcadia Biosciences Annual Income Statement (NASDAQ:RKDA)

Add to My Stocks
$0.9 $0.06 (6.05%) RKDA stock closing price Jan 17, 2017 (Closing)

Fundamental analysis of RKDA stock involves analyzing its financial statements, apart from checking the Arcadia Biosciences stock price In the income statement, an investor can check for important parameters like the topline, the bottomline, the EPS basic, dividends etc. The income statement for RKDA which implies a YoY revenue decline of $1.57M is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Along with Arcadia Biosciences assets and Arcadia Biosciences free cash flow, profits as shown in profit and loss statement give key insights about the business. The profits have increased from $-18.33M YoY and 2015 revenue is $5.41M. Arcadia Biosciences revenue for 2015 is $5.41M. View revenue and profit details for latest and last 10 financial years.

show more
Fiscal year is Jan - Dec. 2015 2014 2013
Arcadia Biosciences Net Sales or Revenues
5.41M6.98M6.47M
Cost Of Goods Sold (COGS)0.89M1.99M0.67M
Arcadia Biosciences Gross Profit
4.52M4.98M5.8M
Research & Development Expense8.96M10.01M8.4M
Selling General & Admin Expense11.11M10.12M7.96M
Income Before Depreciation Depletion Amortization-15.56M-15.15M-10.56M
Depreciation Depletion Amortization---
Non Operating Income0.29M-0.59M0.01M
Interest Expense2.65M1.39M0.62M
Arcadia Biosciences Pretax Income
-17.93M-17.14M-11.18M
Provision for Income Taxes0.02M0.26M0.16M
Minority Interest---
Investment Gains Losses--0.93M-1.84M
Other Income---
Income Before Extraordinaries & Disc Operations-17.95M-18.33M-13.19M
Extraordinary Items & Discontinued Operations---
Arcadia Biosciences Net Income (Profit/Loss)
-17.95M-18.33M-13.19M
Average Shares used to compute Diluted EPS28.56M2.06M-
Average Shares used to compute Basic EPS28.56M2.06M-
Income Before Nonrecurring Items-17.73M-18.34M-
Income from Nonrecurring Items-0.23M--
Arcadia Biosciences Earnings Per Share Basic Net
-0.73-10.71-
Arcadia Biosciences Earnings Per Share Diluted Net
-0.73-10.71-
EPS Diluted Before Nonrecurring Items-0.72-10.71-
Preferred Dividends Acc Pd---
Dividends Common---
Dividend Per Share Common---
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Income statement for another ticker

Before investing one should read a report on Arcadia Biosciences stock analysis. It helps to look at the following income statement items:
  • Revenue: This is the inflow that is generated from the sale of goods or services and is $5.41M for this year of 2015. Our Arcadia Biosciences revenue chart gives a clear visual representation of how the topline growth has been. Investors often invest in only those companies where the revenue is growing at a steady rate.
  • Bottom line: The Bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $5.41M - other expenses = $-17.95M for RKDA stock. An improving bottomline implies that the company is growing profits.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Arcadia Biosciences historical stock prices to check how the price has moved with time. .

Arcadia Biosciences Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
)
10.6266
Operating margin
-363
Net profit margin
-387
Dividend yield
0%